RecruitingNCT05126589

Respiratory Virus Metagenomics After COVID-19

Metagenomic Study on the Distributive Pattern of Respiratory Virus in the Community After the Emergence of COVID-19


Sponsor

Chinese University of Hong Kong

Enrollment

500 participants

Start Date

Dec 28, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The study aims to characterize the distributive pattern of viruses in upper airway and its relationship with influenza seasons, symptomatology and exposure setting. A total of 500 adults residing in Hong Kong would be recruited, who would complete a questionnaire and return self-collected nasal and throat swabs for metagenomic analyses.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with covid-19 respiratory infection. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Prince of Wales Hospital

Hong Kong, Hong Kong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05126589


Related Trials